A research study of a new medicine (NNC0650-0013) in healthy men
NN9650-5027
Phase 1 other active
Quick answer
A research study of a new medicine (NNC0650-0013) in healthy men for Weight management, Diabetes mellitus type 2; healthy subjects is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Weight management, Diabetes mellitus type 2; healthy subjects
- Phase
- Phase 1
- Modality
- other
- Status
- active